Cutler Group’s cbdMD YCBD Stock Holding History

Cutler Group’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$3K	–	6471
2021 Q1	$3K	Buy	+50	New	+$72.7K	﹤0.01%	4787

Other funds holding YCBD

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Cutler Group's YCBD Position: Q4 2021 in Review

Cutler Group sold out of cbdMD (YCBD) in Q4 2021, closing a stake of 5 shares — an estimated $2.91K sold.

Cutler Group first reported a position in YCBD in Q2 2020 and held it in 6 quarters. The position peaked at $18K in Q3 2020. 52 funds tracked by Wall St. Rank hold YCBD as of Q4 2021.

Cutler Group reported no remaining cbdMD position as of Q4 2021 after selling out during the quarter.
Cutler Group sold 5 cbdMD shares in Q4 2021, an estimated $2.91K.
Cutler Group first reported a position in cbdMD in Q2 2020 and held it in 6 quarters.
Cutler Group's cbdMD position peaked at $18K in Q3 2020.
52 funds tracked by Wall St. Rank held cbdMD as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.